DRUG · NASDAQ

Bright Minds Biosciences Inc.

Q: How do I get DRUG news from the API?

Call GET /v1/news?tickers=DRUG. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

$18.49 -3.11 (-14.40%)

Company overview

Bright Minds Biosciences Inc. is a preclinical biosciences company that develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaborations with the National Institutes of Health for the treatment of epilepsy, the University of Texas Medical Branch to treat impulse control disorders such as binge eating, and the Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
Market cap: $182M
Employees: 26
Headquarters: New York, NY
Website: brightmindsbio.com
CEO: Ian McDonald
Listed: March 22, 2021
P/E: -5.79
Dividend yield: 0.00%

Company financials

Revenue: $0.00
Gross profit: -$20,130
Operating income: -$31.4M
EBITDA: -$31.4M
Net income: -$27.5M
EPS: -$3.24
Total assets: $312M
Total debt: $82,071
Earnings yield: -17.26%

Price chart

DRUG 1D NASDAQ O25.07H26.69L21.09C21.55-4.65 (-17.75%)Vol995.46K

News

Ticker	Type	Headline	Source	Published
DRUGBright Minds Biosciences Inc.	Legal	BRIGHT MINDS BIOSCIENCES INVESTIGATION: DRUG Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights	GlobeNewswire	Nov 4, 2:01:41 PM ET
DRUGBright Minds Biosciences Inc.	Legal	DRUG Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Bright Minds Biosciences (DRUG)	ACCESS Newswire	Nov 4, 10:10:00 AM ET
DRUGBright Minds Biosciences Inc.	Legal	Bright Minds Biosciences Inc. (DRUG) Securities Fraud Investigation - Levi & Korsinsky	ACCESS Newswire	Nov 3, 5:15:02 PM ET
DRUGBright Minds Biosciences Inc.	Legal	DRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences	PR Newswire	Nov 3, 2:53:03 PM ET
DRUGBright Minds Biosciences Inc.	Legal	Bright Minds Biosciences Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Bright Minds Biosciences (DRUG)	PR Newswire	Nov 2, 6:26:02 PM ET
DRUGBright Minds Biosciences Inc.	Legal	Levi & Korsinsky Announces Investigation of Securities Claims Against Bright Minds Biosciences Inc. (DRUG)	ACCESS Newswire	Nov 2, 6:00:16 PM ET
DRUGBright Minds Biosciences Inc.	Legal	Bright Minds Biosciences Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Bright Minds Biosciences Inc. (DRUG)	ACCESS Newswire	Nov 2, 4:52:00 PM ET
DRUGBright Minds Biosciences Inc.	Stock news	BUZZ-Bright Minds Biosciences plunges after FDA puts epilepsy drug trial on partial hold	Reuters	Nov 2, 10:30:06 AM ET
DRUGBright Minds Biosciences Inc.	Stock news	BUZZ-Bright Minds Biosciences plunges after FDA puts epilepsy drug trial on partial hold	Reuters	Nov 2, 8:33:52 AM ET
DRUGBright Minds Biosciences Inc.	Press release	Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies	GlobeNewswire	Nov 2, 7:30:00 AM ET
DRUGBright Minds Biosciences Inc.	Press release	CUMBERLAND PHARMACEUTICALS ANNOUNCES PLANS TO FILE NEW DRUG APPLICATION FOR IFETROBAN DMD PROGRAM Cumberland Pharmaceuticals Inc.	PR Newswire	Oct 26, 4:40:00 PM ET
DRUGBright Minds Biosciences Inc.	Stock news	Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference	GlobeNewswire	Sep 30, 5:30:00 PM ET
DRUGBright Minds Biosciences Inc.	Press release	Bright Minds Biosciences to Present at Upcoming Conferences	GlobeNewswire	Sep 4, 4:30:00 PM ET
DRUGBright Minds Biosciences Inc.	Stock news	What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?	Zacks Investment Research	Aug 27, 1:00:26 PM ET
DRUGBright Minds Biosciences Inc.	Stock news	Wall Street Analysts See a 97.01% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?	Zacks Investment Research	Aug 26, 10:55:30 AM ET
DRUGBright Minds Biosciences Inc.	Stock news	Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 97.4%: Read This Before Placing a Bet	Zacks Investment Research	Aug 10, 10:57:19 AM ET
DRUGBright Minds Biosciences Inc.	Stock news	Wall Street Analysts See a 107.53% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?	Zacks Investment Research	Jul 23, 10:56:00 AM ET
DRUGBright Minds Biosciences Inc.	Stock news	All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy	Zacks Investment Research	Jul 22, 1:02:07 PM ET
DRUGBright Minds Biosciences Inc.	Stock news	Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline	Fool - Investing News	May 21, 5:31:11 PM ET
DRUGBright Minds Biosciences Inc.	Stock news	Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy	Fool - Investing News	May 16, 10:41:01 AM ET

FAQ

Questions about Bright Minds Biosciences Inc.

What does Bright Minds Biosciences Inc. do?

What is DRUG's market cap?

Bright Minds Biosciences Inc. (DRUG) is a listed stock with a live quote. The latest market cap on this page is $182M.

Where is Bright Minds Biosciences Inc. headquartered?

Bright Minds Biosciences Inc. is headquartered in New York, NY.

How do I get DRUG news from the API?

Call GET /v1/news?tickers=DRUG. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

How far back does DRUG news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for DRUG, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.

Is the DRUG price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Can I use the Pro plan commercially?

No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs